Head-to-head · Cost-Efficiency Index
ShedRx (Shed) vs Emerge Weight Loss
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
ShedRx (Shed)
People who want a needle-free route or a brand-name option, and who will commit to twelve months to reach the lowest price.
Visit ShedRx (Shed)Emerge Weight Loss
Patients committed to tirzepatide as their drug of choice.
Visit Emerge Weight LossThe verdict
ShedRx (Shed) takes it, leading the Cost-Efficiency Index 87 to 57. The widest set of formats on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound route — though its cheapest advertised rates need a year-long commitment. Emerge Weight Loss still earns a C — Patients committed to tirzepatide as their drug of choice.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs ShedRx (Shed).
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | ShedRx (Shed) | Emerge Weight Loss |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 57/100 |
| Semaglutide / mo | $199/mo ($159 on a 12-month plan) | Not disclosed |
| Tirzepatide / mo | $299/mo ($239 on a 12-month plan) | $287/mo (2.5 mg dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $3,588 | $3,444 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank on the board | #3 | #269 |
ShedRx (Shed)
87/100Where the value is
- Four routes to a GLP-1 — injection, liquid drops, lozenges and a daily oral pill
- Brand Zepbound and Wegovy available alongside the compounded line
- Available in all 50 states, with health coaching included and a published 120-day weight-loss guarantee
The tradeoffs
- The advertised "as low as" prices ($159 semaglutide, $239 tirzepatide) require a TWELVE-MONTH commitment — month-to-month is $199 and $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Emerge Weight Loss
57/100Where the value is
- Tirzepatide-focused (largest effect-size compounded GLP-1)
- Wide dose range available
- Physician-supervised telemedicine model
The tradeoffs
- Semaglutide is available only on request — the site and default plans are tirzepatide-only
- Less brand recognition than Henry Meds, Mochi, or SkinnyRx
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.